Daniela Fiori Gradia
Overview
Explore the profile of Daniela Fiori Gradia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
294
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cupertino S, Goncalves A, Gusmao Lopes C, Gradia D, Beltrame M
Genes (Basel)
. 2025 Feb;
16(2).
PMID: 40004528
Breast cancer (BC) constitutes a significant global health burden, particularly among women, with disparities observed across populations. Notably, women of African ancestry often experience BC at earlier ages and in...
2.
de Azevedo A, Gomig T, Batista M, de Oliveira J, Cavalli I, Gradia D, et al.
Lab Invest
. 2024 Oct;
104(12):102150.
PMID: 39393531
Breast cancer is a highly heterogeneous disease characterized by different subtypes arising from molecular alterations that give the disease different phenotypes, clinical behaviors, and prognostic. The noncoding RNA (ncRNA)-derived micropeptides...
3.
Mathias C, Rodrigues A, Baal S, de Azevedo A, Kozak V, Ferreira Alves L, et al.
Wiley Interdiscip Rev RNA
. 2024 Sep;
15(5):e1870.
PMID: 39268566
Cellular compartmentalization, achieved through membrane-based compartments, is a fundamental aspect of cell biology that contributes to the evolutionary success of cells. While organelles have traditionally been the focus of research,...
4.
Rodrigues C, Spinardi J, Rosa R, Falavigna M, de Souza E, Manfio J, et al.
Immunol Lett
. 2024 Jul;
269:106903.
PMID: 39069096
Objective: To estimate original wild-type BNT162b2 effectiveness against symptomatic Omicron infection among children 5-11 years of age. Methods: This prospective test-negative, case-control study was conducted in Toledo, southern Brazil, from...
5.
de Souza I, Iulini M, Galbiati V, Rodrigues A, Gradia D, Andrade A, et al.
Arch Toxicol
. 2024 May;
98(7):2153-2171.
PMID: 38806720
Diisopentyl phthalate (DiPeP) is primarily used as a plasticizer or additive within the production of polyvinyl chloride (PVC), and has many additional industrial applications. Its metabolites were recently found in...
6.
Veiga R, de Azevedo A, de Oliveira J, Gradia D
J Mol Med (Berl)
. 2024 Feb;
102(4):479-493.
PMID: 38393661
Erythropoietin-producing hepatocellular A2 (EphA2) is a vital member of the Eph tyrosine kinase receptor family and has been associated with developmental processes. However, it is often overexpressed in tumors and...
7.
Abreu H, Royer C, Poitevin C, Kohler A, Rodrigues A, Raboni S, et al.
Viruses
. 2023 Dec;
15(12).
PMID: 38140593
After the Coronavirus pandemic, the importance of virus surveillance was highlighted, reinforcing the constant necessity of discussing and updating the methods for collection and diagnoses, including for other respiratory viruses....
8.
Mathias C, Kozak V, Magno J, Baal S, Dos Santos V, Ribeiro E, et al.
Cancers (Basel)
. 2023 Oct;
15(19).
PMID: 37835376
As immune checkpoint inhibitors (ICI) emerge as a paradigm-shifting treatment option for patients with advanced or metastatic cancer, there is a growing demand for biomarkers that can distinguish which patients...
9.
Rosa R, Falavigna M, Manfio J, de Araujo C, Cohen M, Barbosa G, et al.
Vaccine
. 2023 Jul;
41(37):5461-5468.
PMID: 37507274
Background: Evidence regarding effectiveness of BNT162b2 mRNA COVID-19 vaccine against Omicron in Latin America is limited. We estimated BNT162b2 effectiveness against symptomatic COVID-19 in Brazil when Omicron was predominant. Methods:...
10.
Azevedo A, Gomig T, Batista M, Marchini F, Spautz C, Rabinovich I, et al.
J Proteomics
. 2023 Jun;
285:104955.
PMID: 37390896
Background And Aims: The actual classification of breast tumors in subtypes represents an attempt to stratify patients into clinically cohesive groups, nevertheless, clinicians still lack reproducible and reliable protein biomarkers...